Accès gratuit
Numéro
Ann. Fr. Med. Urgence
Volume 9, Numéro 2, Avril 2019
Page(s) 102 - 111
Section Mise Au Point / Update
DOI https://doi.org/10.3166/afmu-2018-0108
Publié en ligne 11 février 2019
  • Gumz ML, Rabinowitz L, Wingo CS (2015) An integrated view of potassium homeostasis. N Engl J Med 373:60–72 [CrossRef] [PubMed] [Google Scholar]
  • Weiner ID, Linas SL, Wingo CS (2010) Chapter 9 — Disorders of potassium metabolism. In: Floege J, Johnson RJ, Feehally J (eds) Compr Clin Nephrol, Fourth Ed. Mosby, Philadelphia, pp 118–29 [CrossRef] [Google Scholar]
  • Rossignol P, Legrand M, Kosiborod M, et al (2016) Emergency management of severe hyperkalemia: guideline for best practice and opportunities for the future. Pharmacol Res 113:585–91 [CrossRef] [PubMed] [Google Scholar]
  • Sood MM, Sood AR, Richardson R (2007) Emergency management and commonly encountered outpatient scenarios in patients with hyperkalemia. Mayo Clin Proc 82:1553–61 [CrossRef] [PubMed] [Google Scholar]
  • Einhorn LM, Zhan M, Hsu VD, et al (2009) The frequency of hyperkalemia and its significance in chronic kidney disease. Arch Intern Med 169:1156–62 [CrossRef] [PubMed] [Google Scholar]
  • McMahon GM, Mendu ML, Gibbons FK, et al (2012) Association between hyperkalemia at critical care initiation and mortality. Intensive Care Med 38:1834–42 [CrossRef] [PubMed] [Google Scholar]
  • Jain N, Kotla S, Little BB, et al (2012) Predictors of hyperkalemia and death in patients with cardiac and renal disease. Am J Cardiol 109:1510–13 [CrossRef] [PubMed] [Google Scholar]
  • Pepin J, Shields C (2012) Advances in diagnosis and management of hypokalemic and hyperkalemic emergencies. Emerg Med Pract 14:1–17 [Google Scholar]
  • Alfonzo AVM, Isles C, Geddes C, et al (2006) Potassium disorders — clinical spectrum and emergency management. Resuscitation 70:10–25 [CrossRef] [PubMed] [Google Scholar]
  • Faubel S, Shah PB (2016) Immediate consequences of acute kidney injury: the impact of traditional and nontraditional complications on mortality in acute kidney injury. Adv Chronic Kidney Dis 23:179–85 [CrossRef] [PubMed] [Google Scholar]
  • Muschart X, Boulouffe C, Jamart J, et al (2014) A determination of the current causes of hyperkalaemia and whether they have changed over the past 25 years. Acta Clin Belg 69:280–4 [CrossRef] [Google Scholar]
  • Thind GS, Loehrke M, Wilt JL (2018) Acute cardiorenal syndrome: mechanisms and clinical implications. Cleve Clin J Med 85:231–9 [CrossRef] [PubMed] [Google Scholar]
  • Weisberg LS (2008) Management of severe hyperkalemia: Crit Care Med 36:3246–51 [CrossRef] [PubMed] [Google Scholar]
  • Mattu A, Brady WJ, Robinson DA (2000) Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med 18:721–9 [CrossRef] [Google Scholar]
  • Wrenn KD, Slovis CM, Slovis BS (1991) The ability of physicians to predict hyperkalemia from the ECG. Ann Emerg Med 20:1229–32 [CrossRef] [PubMed] [Google Scholar]
  • Acker CG, Johnson JP, Palevsky PM, et al (1998) Hyperkalemia in hospitalized patients: causes, adequacy of treatment, and results of an attempt to improve physician compliance with published therapy guidelines. Arch Intern Med 158:917–24 [CrossRef] [PubMed] [Google Scholar]
  • Szerlip HM, Weiss J, Singer I (1986) Profound hyperkalemia without electrocardiographic manifestations. Am J Kidney Dis 7:461–5 [CrossRef] [PubMed] [Google Scholar]
  • Montague BT, Ouellette JR, Buller GK (2008) Retrospective review of the frequency of ECG changes in hyperkalemia. Clin J Am Soc Nephrol 3:324–30 [CrossRef] [PubMed] [Google Scholar]
  • Surawicz B, Chlebus H, Mazzoleni A (1967) Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K. Am Heart J 73:647–64 [CrossRef] [PubMed] [Google Scholar]
  • Elliott MJ, Ronksley PE, Clase CM, et al (2010) Management of patients with acute hyperkalemia. CMAJ 182:1631–5 [CrossRef] [PubMed] [Google Scholar]
  • Mahoney BA, Smith WA, Lo DS, et al (2005) Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev 2: CD003235. [Google Scholar]
  • Kovesdy CP (2015) Management of hyperkalemia: an update for the internist. Am J Med 128:1281–7 [CrossRef] [Google Scholar]
  • Batterink J, Cessford TA, Taylor RA (2015) Pharmacological interventions for the acute management of hyperkalaemia in adults. Cochrane Database Syst Rev 10:CD010344 [Google Scholar]
  • Allon M, Dunlay R, Copkney C (1989) Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Ann Intern Med 110:426–9 [CrossRef] [PubMed] [Google Scholar]
  • Allon M, Copkney C (1990) Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney Int 38:869–72 [CrossRef] [PubMed] [Google Scholar]
  • Allon M, Shanklin N (1996) Effect of bicarbonate administration on plasma potassium in dialysis patients: Interactions with insulin and albuterol. Am J Kidney Dis 28:508–14 [CrossRef] [PubMed] [Google Scholar]
  • Allon M, Shanklin N (1995) Effect of albuterol treatment on subsequent dialytic potassium removal. Am J Kidney Dis 26:607–13 [CrossRef] [PubMed] [Google Scholar]
  • Montoliu J, Almirall J, Ponz E, et al (1990) Treatment of hyperkalaemia in renal failure with salbutamol inhalation. J Intern Med 228:35–7 [CrossRef] [Google Scholar]
  • Pancu D, LaFlamme M, Evans E, et al (2003) Levalbuterol is as effective as racemic albuterol in lowering serum potassium. J Emerg Med 25:13–6 [CrossRef] [PubMed] [Google Scholar]
  • Blumberg A, Weidmann P, Shaw S, et al (1988) Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med 85:507–12 [CrossRef] [PubMed] [Google Scholar]
  • Lens XM, Montoliu J, Cases A, et al (1989) Treatment of hyperkalaemia in renal failure: salbutamol v. insulin. Nephrol Dial Transplant 4:228–32 [CrossRef] [PubMed] [Google Scholar]
  • Ljutić D, Rumboldt Z (1993) Should glucose be administered before, with, or after insulin, in the management of hyperkalemia? Ren Fail 15:73–6 [CrossRef] [PubMed] [Google Scholar]
  • Kim HJ (1996) Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients. Nephron 72:476–82 [CrossRef] [PubMed] [Google Scholar]
  • Duranay M, Ateş K, Ertürk S, et al (1996) Comparison of aminophylline and insulin infusions in treatment of hyperkalemia in patients with end-stage renal disease. Nephron 73:105 [CrossRef] [PubMed] [Google Scholar]
  • Ngugi NN, McLigeyo SO, Kayima JK (1997) Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East Afr Med J 74:503–9 [PubMed] [Google Scholar]
  • Chothia MY, Halperin ML, Rensburg MA, et al (2014) Bolus administration of intravenous glucose in the treatment of hyperkalemia: a randomized controlled trial. Nephron Physiol 126:1–8 [CrossRef] [PubMed] [Google Scholar]
  • Harel Z, Kamel KS (2016) Optimal dose and method of administration of intravenous insulin in the management of emergency hyperkalemia: a systematic review. PLoS One 11:e0154963 [CrossRef] [PubMed] [Google Scholar]
  • Wheeler DT, Schafers SJ, Horwedel TA, et al (2016) Weightbased insulin dosing for acute hyperkalemia results in less hypoglycemia. J Hosp Med 11:355–7 [CrossRef] [Google Scholar]
  • McNicholas BA, Pham MH, Carli K, et al (2018) Treatment of hyperkalemia with a low-dose insulin protocol is effective and results in reduced hypoglycemia. Kidney Int Rep 3:328–36 [CrossRef] [PubMed] [Google Scholar]
  • Schafers S, Naunheim R, Vijayan A, et al (2012) Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment. J Hosp Med 7:239–42 [CrossRef] [Google Scholar]
  • Sterns RH, Grieff M, Bernstein PL (2016) Treatment of hyperkalemia: something old, something new. Kidney Int 89:546–54 [CrossRef] [PubMed] [Google Scholar]
  • Abuelo JG (2018) Treatment of severe hyperkalemia: confronting 4 fallacies. Kidney Int Rep 3:47–55 [CrossRef] [PubMed] [Google Scholar]
  • Sterns RH, Rojas M, Bernstein P, et al (2010) Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective? J Am Soc Nephrol 21:733–5 [CrossRef] [PubMed] [Google Scholar]
  • Batterink J, Lin J, Au-Yeung SHM, et al (2015) Effectiveness of sodium polystyrene sulfonate for short-term treatment of hyperkalemia. Can J Hosp Pharm 68:296–303 [PubMed] [Google Scholar]
  • Rafique Z, Kosiborod M, Clark CL, et al (2017) Study design of Real World Evidence for Treatment of Hyperkalemia in the Emergency Department (REVEAL-ED): a multicenter, prospective, observational study. Clin Exp Emerg Med 4:154–9 [CrossRef] [PubMed] [Google Scholar]
  • Pitt B, Bakris GL (2015) New potassium binders for the treatment of hyperkalemia: current data and opportunities for the future. Hypertension 66:731–8 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.